twitter

Tuesday, 27 June 2017

Discovery of the fossil otter Enhydritherium terraenovae (Carnivora, Mammalia) in Mexico reconciles a palaeozoogeographic mystery.

 2017 Jun;13(6). pii: 20170259. doi: 10.1098/rsbl.2017.0259.


Author information

1
Department of Pathology and Anatomical Sciences, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY 14214, USA jacktsen@buffalo.edu.
2
Department of Vertebrate Paleontology, Natural History Museum of Los Angeles County, 900 Exposition Boulevard, Los Angeles, CA 90007, USA.
3
Division of Paleontology, American Museum of Natural History, Central Park West at 79th Street, New York, NY 10024, USA.
4
Centro de Geociencias, Universidad Nacional Autónoma de México, Boulevard Juriquilla 3001, Juriquilla, Querétaro 76230, Mexico.

Abstract

The North American fossil otter Enhydritherium terraenovae is thought to be partially convergent in ecological niche with the living sea otter Enhydra lutris, both having low-crowned crushing teeth and a close association with marine environments. Fossil records of Enhydritherium are found in mostly marginal marine deposits in California and Florida; despite presence of very rich records of fossil terrestrial mammals in contemporaneous localities inland, no Enhydritherium fossils are hitherto known in interior North America. Here we report the first occurrence of Enhydritherium outside of Florida and California, in a land-locked terrestrial mammal fauna of the upper Miocene deposits of Juchipila Basin, Zacatecas State, Mexico. This new occurrence of Enhydritherium is at least 200 km from the modern Pacific coastline, and nearly 600 km from the Gulf of Mexico. Besides providing further evidence that Enhydritherium was not dependent on coastal marine environments as originally interpreted, this discovery leads us to propose a new east-to-west dispersal route between the Florida and California Enhydritherium populations through central Mexico. The proximity of the fossil locality to nearby populations of modern neotropical otters Lontra longicaudis suggests that trans-Mexican freshwater corridors for vertebrate species in riparian habitats may have persisted for a prolonged period of time, pre-dating the Great American Biotic Interchange.

KEYWORDS:

Carnivora; Hemphillian; Mustelidae; biogeography; otter; zoogeography
PMID:
 
28615353
 
DOI:
 
10.1098/rsbl.2017.0259

Elwood Richard 1931-2017




by Hannah Bauman

HerbalGram. 2017; American Botanical Council


Elwood Richard, founder of natural products and dietary supplement industry leader NOW, died on April 7, 2017, after a lengthy battle with mesothelioma. He will be remembered for the significant impact he made on the natural food and dietary supplement industries over the course of almost six decades.
Richard’s introduction to natural foods began when his father, Paul Richard, bought Fearn Soya and developed the industry’s first soy  (Glycine max, Fabaceae) protein supplement product. Elwood Richard, with a bachelor’s degree in chemistry from Monmouth College in Monmouth, Illinois, and graduate studies in physical chemistry and biochemistry at Indiana University, stepped in to run Fearn in 1960 after his father’s death, with input from his brothers Bill and Lou. In 1962, Richard opened his first health food store, the Health House. Eventually renamed The Fruitful Yield, the Chicago-based retail chain currently operates 13 stores. In 1968, Richard founded NOW. His brother Lou would later join the company full time, and together they worked with early quality programs of the National Nutritional Foods Association (NNFA, now the Natural Products Association [NPA]) Standards Committee.
Richard led NOW through decades of growth, expanding product lines and manufacturing facilities, and he never wavered from his original belief that good health should be available to everyone. He also ensured that the company’s mission of empowering people to lead healthier lives would never be compromised by short-term profit demands. Through Richard's legacy planning and gifting of shares to family members, NOW currently has about 40 owners from the Richard family, and it is well positioned for future generations, according to information on the company's website.
When Richard retired as CEO in 2005, succeeded by long-time Fruitful Yield and NOW employee Al Powers, he stayed very much involved in the business and the industry as the chair of the NOW Board of Directors, and a member of the NOW Advocacy Team, the NOW Strategy Team, and the NOW Environmental Team. He was also on the managing board of the Natural Health Research Institute (NHRI), a nonprofit organization he founded that is committed to informing consumers, scientists, the media, policymakers, and legislators about scientific evidence on the usefulness and cost-effectiveness of a good diet, supplements, and a healthy lifestyle.
NOW CEO Jim Emme, a veteran of the company for 22 years, commented: “His passion in defending consumer choice in the industry with logic and with scientific knowledge he had as a physical chemist came through many, many times. One of the legacies he left is the Golden Rule, treating others as you want to be treated. He lived that every day that I knew him.”
Former NOW CEO Powers also recalled Richard’s energetic commitment to the company’s mission. “El was a truly great man and a great entrepreneur. He was always passionate about the health food industry, and the success of the NOW brand is a testimony to his vision, leadership, and dedication to our mission and our industry. He will always be remembered for his love, generosity, and kindness that touched the lives of everyone at NOW. He was the heart and soul of NOW Foods.”
“This year is my 20th year working for Elwood Richard’s companies,” wrote Neil E. Levin, CCN, DANLA, a nutritionist, writer, and educator who works at NOW (email to M. Blumenthal, April 14, 2017). “I found him to be unfailingly polite, kind, inquisitive, generous, and fully committed to the natural products industry. He was always interested in me, both as an employee and as a fellow natural products enthusiast, frequently taking time to ask about me, my work, and my family, including my wife’s organic garden.”
“His work ethic, deep faith, tolerance, family values, and belief in the Golden Rule have driven the success of his businesses without losing the love and respect of his family, friends, employees, customers, and even business competitors,” Levin continued. “He constantly visited health food stores when traveling, even when on vacation. He freely shared best practices and quality methods developed by his employees with the industry without trying to patent or restrict their use for profit, because he believed that we all sink or swim together. He was especially concerned about health freedom and product quality issues, devoting much of his energy to these areas. This focus culminated in his work to support the NHRI, a long-term project close to his heart.”
Richard was recognized by the industry he served for so many decades with numerous honors and awards, including induction into the New Hope Hall of Legends, the NPA Lifetime Achievement Award, the Nutrition Business Journal Lifetime Achievement Award, the NNFA Crusader Award, and, most recently, the American Herbal Products Association (AHPA) Visionary Award.
After the announcement of Richard’s death, his fellow industry leaders came forward to honor his life and legacy. United Natural Products Alliance President Loren Israelsen commemorated Richard’s life in a public comment, stating: “We note with sadness the passing of one of the industry’s true legends, who, as much as anyone in living memory, has shaped the modern natural foods and dietary supplement industries. Elwood combined extraordinary tenacity with a very clear focus on and vision for what he was hoping to accomplish: combining value and quality in his company’s products and to continually invest in his business. He was a force of nature…. His legacy lives on through the NOW team and its continued support of best practices and multiple industry quality initiatives” (email, April 11, 2017).
AHPA President Michael McGuffin was quoted as saying, “I was honored to acknowledge Elwood with the AHPA Visionary Award earlier this year, adding to the already impressive list of awards and honors bestowed upon him by the natural products industry…. His sincere and lifelong commitment to public health greatly benefitted the industry and the public. He will be sorely missed, but his rich legacy makes Elwood impossible to forget.”1
Dan Fabricant, PhD, executive director and CEO of the NPA, remembered Richard’s business savvy and personal involvement with NOW. “One of the things that was so remarkable was that he hired good people and got out of the way,” said Fabricant in a statement to NutraIngredients-USA.1 “He looked to others to add strength, and so many business owners could learn from that.”
In the same article, Steve Mister, president and CEO of the Council for Responsible Nutrition, was quoted as saying, “[Richard] was a true pioneer in the dietary supplement industry and a strong advocate for supplement consumers…. [H]is passion for ‘empowering people to lead healthier lives’ came across in every conversation, every communication, and to everyone who had the opportunity to know and work with him.”
American Botanical Council Founder and Executive Director Mark Blumenthal added: “El was always a consummate gentleman and a true believer in the proposition that natural foods and dietary supplements are necessary elements of a healthy life. He is a genuine pioneer of the natural products community and a strong example of the uniqueness and special character of the people in this community.”
Elwood Richard is survived by his wife Betty, daughter Sharon (Richard) Wong, sons Dan and David, five grandchildren, and one great grandchild. “His sincere humility and great humanity live on in the hearts of his family and friends, and in the ethical and responsible business practices of his company,” concluded Levin. “He will be missed, but will always remain with those who knew him.” 

—Hannah Bauman

Editor’s note: We would like to thank NOW Health Group, Inc., and Neil Levin for their contributions to this tribute, including the use of language from a press release2 and tremendous insight from Mr. Levin.

References
1.     Daniells S. Industry pays tribute to NOW founder Elwood Richard. NutraIngredients-USA website. April 11, 2017. Available here: www.nutraingredients-usa.com/Manufacturers/Industry-pays-tribute-to-NOW-founder-Elwood-Richard. Accessed April 17, 2017.
2.     NOW founder Elwood Richard 9/17/31 – 4/7/17 [press release]. Bloomingdale, IL: NOW Health Group, Inc.; April 10, 2017. Available at: www.nowfoods.com/now/nowledge/now-founder-elwood-richard-91731-4717. Accessed April 17, 2017.

Food as Medicine: Caper (Capparis spinosa, Capparaceae)

HerbalEGram: Volume 14, Issue 5, May 2017


Editor’s Note: Each month, HerbalEGram highlights a conventional food and briefly explores its history, traditional uses, nutritional profile, and modern medicinal research. We also feature a nutritious recipe for an easy-to-prepare dish with each article to encourage readers to experience the extensive benefits of these whole foods. With this series, we hope our readers will gain a new appreciation for the foods they see at the supermarket and frequently include in their diets.
The basic materials for this series were compiled by dietetic interns from Texas State University (TSU) in San Marcos and the University of Texas at Austin (UT) through the American Botanical Council’s (ABC’s) Dietetic Internship Program, led by ABC Education Coordinator Jenny Perez. We would like to acknowledge Perez, ABC Special Projects Director Gayle Engels, and ABC Chief Science Officer Stefan Gafner, PhD, for their contributions to this project.
By Hannah Baumana and Monica Silvab
a HerbalGram Associate Editor
b ABC Dietetics Intern (TSU, 2017)
Overview
The caper (Capparis spinosa, Capparaceae) bush is a small, salt-tolerant shrub with trailing, thorny branches and thick, fleshy leaves. Caper has a deep root system and trailing vines that grow seven to 10 feet tall.1 The semi-prostrate branches have ovate, petiolate leaves arranged opposite of each other. The flowers are pink or white with three petals and numerous stamens. Caper is a deciduous, dicotyledonous plant that produces distinctive flower buds, which have a life span of 24 to 36 hours after opening.1,2
Caper’s edible shoots are considered a vegetable, and its processed buds are considered a culinary herb.1The tender shoots emerge in the spring, while the flower buds are harvested from mid-May to mid-August. Each plant produces hundreds of flowers each season. When pickled in vinegar or brine, the immature flower buds form capric acid, which is responsible for caper’s unique, salty-sour flavor.2,3 Once the flower blooms and is pollinated, it produces a fruit two to three inches in length and one-half to three-quarters of an inch in diameter. Caper fruits start out green, but turn purple when ripe. Each fruit contains 200 to 300 seeds.1 The fruit of the caper bush is also harvested, but not commonly used.2
Currently, capers are cultivated commercially in northern Africa, Spain, and Italy. Caper plants in Cyprus, Greece, and Turkey are grown for domestic use and not for export. The United States imports more than $20 million of processed capers annually.1 Caper plants that are two to three years old produce about two pounds of buds in a year, while plants older than four years may produce more than 20 pounds of buds annually.1
Phytochemicals and Constituents
Macronutrients are found in capers in very small amounts. One tablespoon (8.6 grams) of pickled capers has two calories, half a gram of carbohydrates, and minute amounts of protein and fat. An important micronutrient to consider when eating capers is sodium. One tablespoon of capers contains 202 milligrams of sodium, which is 8.5% of the recommended daily intake for a healthy adult.4,5 The flower bud also contains trace amounts of vitamins C and E. The concentration of vitamins can vary from plant to plant. The vitamin C content in capers cultivated in different regions in Tunisia, for example, ranged from 0.3 to 0.5 milligrams per 100 grams of capers.6
A number of bioactive compounds have been isolated from the flower buds of the caper bush. The pickling process has varying effects on the bioavailability of compounds due to different fermentation methods.7 Among the most investigated of these phytochemicals are flavonoids and antioxidants.
Flavonoids from capers reportedly have cytotoxic, anti-inflammatory, antidiabetic, and antiparasitic properties.7,8 Rutin (quercetin-3-O-rutinoside) is the most abundant flavonoid in fresh and pickled caper buds.7 Simple water extractions high in rutin have been shown to reduce inflammation and arrest cell growth in cancer cells, as well as kill intestinal parasites in animals.8,9 Caper flower buds also contain quercetin-3-O-rhamnosylrutinoside, a derivative of quercetin.6
Quercetin, another well-studied flavonoid, is formed from rutin during the pickling process.7 Quercetin can inhibit inflammation and cancer cell growth in the same way as rutin.9 Quercetin has also shown immune-health benefits. Kaempferol 3-O-rhamnosylrutinoside, another flavonoid identified in an aqueous extract, has proven antiparasitic properties.8
The flower bud of the caper bush also contains antioxidants such as carotenoids, tocopherols, ascorbic acid, and a newly identified antioxidant, cappariside, a small organic acid.6,10 Antioxidants eliminate free radicals that cause damage to body tissues and DNA, and have been implicated in the prevention of cancer, kidney damage, and heart disease, as well as protection against prescription drug-induced toxicity.11 The antioxidant effects of flower bud preparations have been shown to be more potent than those of the antioxidants in isolation.8
Historical and Commercial Uses
The unopened flower buds of the caper bush are commercially known as capers.2 Capers are used as a condiment in salads and sauces, or with meat or fish. They are also used in cosmetics and medicines.
Archeological evidence for the historical use of capers as a food and medicine exists among many ancient cultures.12 The earliest known evidence of caper consumption was found in the Mesolithic soil layer of an excavation site in Syria, potentially dating back to 9000 BCE. Nearby ancient peoples may have been using capers in 7500 BCE as evidenced by mineralized seeds found in the Franchthi cave, a Stone Age cave in the Greek Peloponnesian peninsula. Dried seeds found in the Nahal Hemar cave in Israel may have been used as early as 6000 BCE. In China, fresh clumps of capers and plant parts were preserved in entombed containers that are almost 3,000 years old. There is also evidence of Egyptian consumption of capers from 275 BCE to 600 CE.
Historical medicinal uses of capers ranged from expelling bad odor spirits in ancient Arabic cultures to treating paralysis in ancient Xinjiang, China.12 In addition to the buds, the root bark, fruit, and aerial parts of the caper bush were used in traditional remedies. Countries in the native range of caper, including Iran, Iraq, and Syria, used every part of the caper bush for a variety of ailments. As the cultivation and use of capers spread, the Greeks, Egyptians, and Chinese incorporated the caper bush into their traditional medicine practices.
Capers contain phytochemicals that can inhibit inflammation, which supports caper’s usages as a cleanser and pain reliever.9,12 In ancient Chinese, Greek, and Arabic cultures, the root bark was mixed with vinegar or honey and applied topically to treat skin conditions such as ulcers and white spots associated with vitiligo.12 Similarly, the root was consumed as a treatment for inflammation and lacerations of the mouth, spleen, stomach, and intestines. In ancient Egypt, the root was used to reduce the pain of a scorpion sting.
In ancient Greece and China, the caper bush was regarded for its drying properties and was used as an expectorant in treating wet cough and asthma.12 Ancient Romans boiled caper root and root bark in oil and used it as an anthelmintic (digestive tract parasitic worm expeller). Likewise, in the 12th century, the Egyptians used the root to cleanse and dry the stomach.
Current medicinal usages are a testament to caper’s efficacy for treating different ailments. In the Middle East, indigenous groups still use capers as a so-called “blood purifier” and diuretic, to relieve stomach discomfort, treat kidney stones, improve liver function, and treat eczema.13 In Ayurveda, one of the traditional medicine systems of India, caper is used to treat paralysis and tremors, as well as edema, gout, and rheumatism.14 The root bark is still used to stimulate the menstrual cycle, as an expectorant, and to treat paralysis, rheumatism, spleen conditions, and toothaches.15
Modern Research
Commercial capers are not frequently studied for their medicinal properties. However, some research has been conducted on the bioactive compounds in the flower buds.
A recent study investigated the antiparasitic effect of a caper bud extract against Haemonchus contortus, a common parasite in cows and sheep. The large number of eggs and short life span of H. contortus allows the parasite to adapt quickly to its environment.16 Parasite infestations can result in large economic losses in the animal production industry, and current treatments include chemotherapy and vaccinations, which pose a safety concern.17 Researchers compared the caper extract to a commonly prescribed antiparasitic drug albendazole. The flower bud extract (50 mg/mL) was almost twice as effective as albendazole (1 mg/mL) at killing parasites in sheep and inhibited  the hatching of parasitic eggs more than the leaf extract.8
The caper bud has also been studied for its anti-inflammatory and cytotoxic properties. A recent study investigated the potential of capers to inhibit nuclear factor-kappa B (NF-κB), a transcription factor that controls inflammation and cell growth. Mutations that impact its activation may lead to uncontrolled cell growth, one of the conditions that can cause a proliferation of cancer cells.18 For this reason, NF-κB is a therapeutic target for pancreatic, renal, and thyroid cancer treatments.18-20 In one in vitro study, researchers tested an aqueous extract of the flower bud and leaves, which were selected for their high levels of phenolic compounds, on human adenocarcinoma cells. The caper extract successfully inhibited the inflammation mechanism, and arrested cell growth in a dose-dependent manner.9
Additionally, a caper flower bud extract has been studied for its ability to treat liver toxicity in animals. Rats were exposed to two different liver toxins: carbon tetrachloride, a known carcinogen that has been used as a commercial refrigerant, propellant, and solvent; and paracetamol, also known as acetaminophen, a pain-relieving drug that can induce liver failure in sufficiently high doses.21 Compared to control, the caper extract resulted in a significant reductions in carbon tetrachloride-induced and paracetamol-induced liver toxicity.
Nutrient Profile4
Macronutrient Profile: (Per 1 tablespoon pickled capers, drained)
2 calories
0.2 g protein
0.4 g carbohydrate
0.1 g fat
Secondary Metabolites: (Per 1 tablespoon pickled capers, drained)

Provides small amounts of:
Vitamin K: 2.1 mcg (2.6% DV)
Dietary Fiber: 0.3 g (1.2% DV)

Provides trace amounts of:
Magnesium: 3 mg (0.8% DV)
Vitamin C: 0.4 mg (0.7% DV)
Iron: 0.1 mg (0.6% DV)
Riboflavin: 0.01 mg (0.6% DV)
Folate: 2 mcg (0.5% DV)
Vitamin E: 0.1 mg (0.5% DV)
Manganese: 0.007 mg (0.4% DV)
Calcium: 3 mg (0.3% DV)
Niacin: 0.06 mg (0.3% DV)
Vitamin A: 12 IU (0.2% DV)
Phosphorus: 1 mg (0.1% DV)
Potassium: 3 mg (0.1% DV)
Thiamin: 0.002 mg (0.1% DV)
Vitamin B6: 0.002 mg (0.1% DV)
DV = Daily Value as established by the US Food and Drug Administration, based on a 2,000-calorie diet.

Recipe: Lemon Capellini with Capers
Adapted from Ina Garten22
Ingredients:
  • 1 pound dried capellini pasta
  • 1/3 cup of extra virgin olive oil
  • Zest and juice of two lemons
  • 1/4 cup capers, drained
  • Salt and pepper to taste
Directions:
  1. Cook pasta according to package directions. Before draining, reserve 1/4 cup of pasta cooking water. Drain pasta and return to pot off the heat.
  2. Toss the cooked pasta with olive oil, lemon juice, salt, and pepper, adding pasta water a tablespoon at a time until a thin sauce forms. Discard any remaining pasta water.
  3. Add capers and lemon zest and toss once more to combine. Serve immediately.
References
  1. Kontaxis DG. Specialty Crop: Capers. Davis, CA: University of California Cooperative Extension; 2012. Available at: http://sfp.ucdavis.edu/pubs/SFNews/DecJan97-98/capers_148/. Accessed April 17, 2017.
  2. Van Wyk, BE. Food Plants of the World: An Illustrated Guide. Portland, OR: Timber Press; 2005.
  3. National Geographic Society. Edible: An Illustrated Reference to the World’s Food Plants. Washington DC: National Geographic Society; 2008.
  4. Basic Report: 02054, Capers, canned. United States Department of Agriculture Agricultural Research Service website. Available at: https://ndb.nal.usda.gov/ndb/foods/show/303. Accessed April 6, 2017.
  5. Appendix 7. Nutritional Goals for Age-Sex Groups Based on Dietary Reference Intakes and Dietary Guidelines Recommendations. In: Dietary Guidelines for Americans 2015-2020. 8th ed. Washington DC: US Department of Health and Human Services and US Department of Agriculture; 2015.
  6. Tlili N, Khaldi A, Triki S, Munné-Bosch S. Phenolic compounds and vitamin antioxidants of caper (Capparis spinosa). Plant Foods Hum Nutr. 2010;65(3):260-265.
  7. Nabavi SF, Maggi F, Daglia M, Habtemariam S, Rastrelli L, Nabavi SM. Pharmacological effects of Capparis spinosa L. Phyother Res. 2016;30:1733-1744.
  8. Akkari H, B’chir F, Hajaji S, et al. Potential anthelmintic effect of Capparis spinosa (Capparidaceae) as related to its polyphenolic content and antioxidant activity. Veterinární Medicína. 2016;61(6):308-316.
  9. Kulisic-Bilusic T, Schmöller I, Schnäbele K, Siracusa L, Ruberto G. The anticarcinogenic potential of essential oil and aqueous infusion from caper (Capparis spinosa L.). Food Chem. 2012;132(1):261-267.
  10. Yang T, Wang C, Liu H, Chou G, Cheng X, Wang Z. A new antioxidant compound from Capparis spinosaPharm Biol. 2010;48(5):589-594.
  11. Kaur CK, Kapoor HC. Antioxidants in fruits and vegetables — the millennium’s health. International Journal of Food Science and Technology. 2001;36(7):703-725.
  12. Jiang HE, Li X, Ferguson DK, Wang YF, Liu CJ, Li CS. The discovery of Capparis spinosa L. (Capparidaceae) in the Yanghai tombs (2800 years b.p.), NW China, and its medicinal implications. J Ethnopharmacol. 2007;113(3):409-420.
  13. Sher H, AlMutairi K, Mansoor M. Study on the ethnopharmaceutical values and traditional uses of Capparis spinosa L. African Journal of Pharmacy and Pharmacology. 2012;6(16):1255-1259.
  14. Nadkarni K. Indian Materia Medica. Vol 1. Bombay, India: Bombay Popular Prakashan; 1976.
  15. Duke J. Duke’s Handbook of Medicinal Plants of the Bible. Boca Raton, FL: CRC Press; 2008.
  16. Emery DL, Hunt PW, Le Jambre LF. Haemonchus contortus: the then and now, and where to from here? Int J Parasitol. 2016;46(12):755-769.
  17. Kebede B, Sori T, Kumssa B. Review on current status of vaccines against parasitic diseases of animals. J Veterinar Sci Techno. 2015;7(3):27.
  18. Tunçel D. Role of NF-kappa b in the approach to pancreatic ductal adenocarcinoma. Archives Medical Review Journal. 2015;24(4):565-577.
  19. Li X, Abdel-Mageed AB, Mondal D, Kandil E. The nuclear factor kappa-B signaling pathway as a therapeutic target against thyroid cancers. Thyroid. 2013;23(2):209-218.
  20. Peri S, Devarajan K, Yang DH, Knudson AG, Balachandran S. Meta-analysis identifies NF-kappaB as a therapeutic target in renal cancer. PLoS One. 2013;8(10):e76746.
  21. Chhaya G, Mishra SH. Antihepatotoxic activity of p-methoxy benzoic avid from Capparis spinosaJ Ethnopharmacol. 1999;66:187-192.
  22. Garten I. Lemon capellini with caviar. Food Network Magazine. Available at: www.foodnetwork.com/recipes/ina-garten/lemon-capellini-with-caviar. Accessed April 6, 2017.

Re: Hibiscus Water Extract Demonstrates Significant Antioxidant Effects in Patients with Marfan Syndrome

  • Hibiscus (Hibiscus sabdariffa, Malvaceae)
  • Marfan Syndrome
  • Oxidative Stress
Date: 06-15-2017HC# 111674-570

Soto ME, Zuñiga-Muñoz A, Guarner Lans V, Duran-Hernández EJ, Pérez-Torres I. Infusion of Hibiscus sabdariffa L. modulates oxidative stress in patients with Marfan syndrome. Mediators Inflamm. 2016;2016:8625203. doi: 10.1155/2016/8625203.

Marfan syndrome (MFS) is an autosomal dominant genetic disorder manifesting in persistent oxidative stress and malfunction of connective tissue in the cardiovascular and skeletal systems. Previous studies of hibiscus (Hibiscus sabdariffa, Malvaceae) calyx drinks showed improvements in circulating antioxidant levels in healthy humans. Anthocyanins and organic acids like ascorbic acid are water-soluble antioxidants that are uncharacteristically rich in the hibiscus calyx, the ripened flowering body that is typically dark red in color. The goal of this prospective, observational, single-cohort study was to evaluate if a water infusion of hibiscus consumed daily could improve oxidative stress in patients with MFS.
The 3-month study took place at the National Institute of Cardiology Ignacio Chávez; Mexico City, Mexico. Seventeen patients with MFS and 10 healthy, control subjects were recruited through physical examination at the National Institute of Cardiology Ignacio Chávez. Additional echocardiography, computerized tomography, or magnetic resonance was done to insure no aortic damage, and none of the enrolled patients were on anti-inflammatory medication.
Each patient consumed 1L daily for 3 months of a beverage made from boiling 20 g hibiscus calyces in a liter of boiling water (95-100°C) for 10 minutes, then left to cool. Hibiscus calyces were acquired in Chilapa de Álvarez (high zone from Guerrero, Mexico). Anthocyanins, flavonoids, and ascorbic acid (vitamin C) were estimated in the beverage by ultraviolet spectrometry, although composition data were not included in the study. Circulating levels of superoxide dismutase (SOD), glutathione peroxidase (GPx), glutathione-S-transferase (GST), glutathione reductase (GSHR), glutathione (GSH), lipid peroxidation (LPO) index, total antioxidant capacity (TAC), and ascorbic acid were measured in plasma from patients with MFS.
Levels of all oxidative stress markers were significantly different in patients with MFS versus control subjects. After 3 months of treatment, significant improvements in SOD (P = 0.03), GPx (P = 0.02), GST (P = 0.01), GSHR (P = 0.03), GSH (P = 0.05), LPO index (P = 0.001), and TAC (P = 0.04) were observed in patients with MFS. [Note: The P values in the abstract do not match those found in the text and figures.]
This study adds to existing clinical research on the antioxidant effects of hibiscus calyx beverages in humans. More research should be done to determine whether high-elevation hibiscus could have a different composition than other varieties. Admitted limitations include the small sample size, which was in large part due to the rarity of MFS (occurring in 2 or 3 individuals per 10,000). The long-term effects of hibiscus on slowing the progression of chronic disease related to oxidative stress should be investigated further.
—Blake Ebersole 

Re: Review of Traditional and Non-traditional Uses of Kratom

  • Kratom (Mitragyna speciosa, Rubiaceae)
  • Traditional Uses
  • Emerging Uses
Date: 06-15-2017HC# 111645-570

Singh D, Narayanan S, Vicknasingam B. Traditional and non-traditional uses of mitragynine (kratom): a survey of the literature. Brain Res Bull. September 2016;126(Pt 1):41-46.
Kratom is the name most widely used to describe the leaves of Mitragyna speciosa (Rubiaceae), a tree which is indigenous to South East (SE) Asia. Traditionally, kratom has been used in SE Asia as a mild stimulant to alleviate fatigue and as a treatment for pain, fever, and wounds. The dose-dependent narcotic-like properties of the leaves have been attributed chiefly to the constituent alkaloids mitragynine and 7-hydroxymitragynine, which are stimulating at lower doses and sedating at higher ones. This herb was initially adopted into Western culture as a dietary supplement with analgesic properties; however, the uses of kratom in both SE Asia and Western countries are evolving.
These authors conducted a review of the literature describing the traditional and non-traditional uses of kratom. PubMed, ScienceDirect, and Scopus were searched using the keywords "kratom" and "Mitragyna speciosa." A total of 40 articles referencing human use of kratom were identified—17 describing kratom use in SE Asia and 23 referencing kratom use in the West (Germany, Norway, Sweden, United Kingdom [UK], and United States [US]). It is noted that while kratom is distributed throughout SE Asia, including the Philippines, Borneo, Myanmar, and New Guinea, the publications discussing kratom use were limited to Thailand and Malaysia. The design of the 40 articles were categorized as follows: ten internet-based surveys, eight reviews, 17 case reports, two in-depth interviews, one reference text, two short communications, and one experimental design study. The results were summarized under the following headings: modes of supply, modes of consumption, uses, side effects, addiction, withdrawal effects, legal status, and social status.
In Thailand and Malaysia, the identity of the supplier and the quality of their products are known to the buyer. In the West, the largest volume of kratom is sold anonymously over the internet.
In SE Asia, kratom leaves are chewed, smoked, or decocted to provide a "juice." Due to the bitter taste of the juice, many users prefer to combine it with sweet beverages such as sodas. Modes of consumption in the West must be inferred from the types of kratom merchandise offered for sale, which include powdered leaves, tablets, capsules, gums, pills, smoking preparations, and a variety of combination products.
The use of kratom is common in rural areas of SE Asia. Its medicinal applications include the treatment of fever, diarrhea, pain, and wounds. In addition, it is socially acceptable for male workers to use kratom to enhance physical endurance and relieve stress, whereas female users may be subject to social stigma. The common usage of kratom in Malaysia to reduce illicit substance dependence and ease withdrawal was reported in 2010. Affordable and readily available, researchers found that it allows addicts to self-manage withdrawal and avoid the public shame associated with official treatment programs. The underground use of kratom by young adults in a cocktail with cough syrup or codeine is another emerging trend.
In Western countries, kratom was introduced as an herbal remedy for chronic pain and subsequently also became known as a self-administered treatment for substance withdrawal. More recently, it has been promoted as a euphoric "legal high," and concentrated extracts and mitragynine products are marketed in several forms, including combinations with other substances. [Note: The "Krypton" product associated with nine fatalities in Sweden contained kratom, caffeine, and the synthetic opioid O-desmethyltramadol.]
The primary adverse effects (AEs) associated with regular kratom use in SE Asian populations are reported to be weight loss, dehydration, constipation, hand shaking, headaches, and hyperpigmentation, and in the longer term, lethargy and fatigue. Among Western users, AEs can only be extrapolated from case reports; kratom use has been linked to seizures, hypothyroidism, and liver injury. The authors note that while reports of toxicity and fatalities continue to emerge from the West, none have been reported in SE Asia. Also, many of the fatalities were associated with dependency/abuse of other substances. There are several hypotheses which may explain these findings—higher tolerance to kratom in SE Asia due to its long history of use or AEs are less likely to be reported; the concentrated extracts and mitragynine products consumed in the West are much more toxic compared to the relatively unprocessed leaf products used in SE Asia; and the possibility that Western users may be buying adulterated, contaminated, or misidentified products.
Studies in SE Asia suggest that regular use of kratom leads to dependence. However, unlike opioid addicts, most kratom users remain healthy and a 2014 Malaysian study found no impairment of social functioning. Although studies in the West are lacking, there have been case reports of kratom addiction, and the burgeoning internet sales of kratom suggest that addiction may also be an emerging concern in the West.
Data from SE Asian studies indicates that sudden withdrawal of kratom can cause unpleasant physical and psychological symptoms. Reported physical symptoms include lethargy, irritability, yawning, runny nose, muscle pain, cramps, joint pain, and diarrhea. Psychological symptoms include restlessness, tension, aggression, sadness, nervousness, delusion, hallucination, and intense cravings; anxiety, depression, moodiness, annoyance, and sleeplessness also have been reported. A Malaysian survey found that users who consumed ≥3 glasses/day of kratom juice had greater odds of dependence and withdrawal symptoms. However, it is reported that while kratom withdrawal symptoms are distracting, they are not as painful as opioid withdrawal and the symptoms usually disappear after one to three days. In the West, documentation of kratom withdrawal symptoms are limited to a few case reports, some of which involved other substances.
Kratom is banned in Australia, Bhutan, Malaysia, Myanmar (Burma), and Thailand. However, it is reported that it is still readily available in Malaysia and Thailand. Kratom remains unregulated in the UK and many European countries, although it is controlled in Denmark, Finland, Lithuania, Poland, Romania, and Sweden. In the US, kratom is the subject of an import ban but is not regulated. [Note: In October of 2016, the US Drug Enforcement Administration announced a six-week public consultation on kratom.] It is noted that kratom drug test kits are not available and treatment protocols for kratom dependence have not been developed.
Kratom users in SE Asia may face some family rebuke for their "wasteful" habit but are not considered drug users; they are generally seen as hard-working people who use kratom to work longer hours and earn more money. Surveys indicate that the majority are older adults with regular employment and stable family environments. In traditional Thai culture, kratom was served to guests and was used in ritual worship of ancestors and gods.
In summary, kratom has a long history of safe use in SE Asia with no serious AEs or fatalities associated with its consumption. The authors conclude that "the value of kratom in pain management and opioid withdrawal deserves careful scientific study and evaluation to determine its efficacy, composition, drug interactions and safe dosage limits." They comment that it would be unfortunate if the sporadic case reports of severe AEs or fatalities in the West are used to support the implementation of regulations banning kratom; "any blanket illegalization of kratom poses the danger of casting out the baby with the bathwater." The evidence from SE Asia suggests that kratom has considerable potential as an inexpensive treatment for people who are dependent on more highly addictive substances. Noting that raw kratom leaves lack AEs and have a wide variety of effects depending on the strain and source, the authors suggest future research would be more productive if it was focused on whole kratom leaves rather than isolated constituents like mitragynine. The authors call for international collaboration to conduct the many social and medical research studies that are needed to establish the therapeutic role of kratom.
—Mariann Garner-Wizard 

Catharanthus roseus: The Cancer-Fighting Medicine https://link.springer.com/chapter/10.1007/978-3-319-51620-2_7 #springerlink

Monday, 26 June 2017

Capparis spinosa leaves extract: Source of bioantioxidants with nephroprotective and hepatoprotective effects

 2017 Mar;87:171-179. doi: 10.1016/j.biopha.2016.12.052. Epub 2017 Jan 2.


Author information

1
Laboratoire de biochimie, Faculté des Sciences de Tunis, Université Tunis El-Manar, 2092 Tunis, Tunisie; Institut National de Recherches en Génie Rural, Eaux et Forêts, Université de Carthage, BP 10, Ariana 2080, Tunisie. Electronic address: Nizar.Tlili@fst.rnu.tn.
2
Unité de Biochimie Macromoléculaire et Génétique, Faculté des Sciences de Gafsa, cité Zarroug, Université de Gafsa, 2112 Gafsa, Tunisie; Laboratoire d'Ecophysiologie Animale, Faculté des Sciences de Sfax, Tunisia.
3
Institut National de Recherches en Génie Rural, Eaux et Forêts, Université de Carthage, BP 10, Ariana 2080, Tunisie.
4
Laboratoire de biochimie, Faculté des Sciences de Tunis, Université Tunis El-Manar, 2092 Tunis, Tunisie.

Abstract

Capparis spinosa, Capparidaceae, is largely distributed all over the Mediterranean Basin and is traditionally used to treat many illnesses, such as liver and kidney diseases. The aim of the current study was to explore the antioxidant, nephroprotective and hepatoprotective effects of methanolic extract of Capparis spinosa leaves (MECS) associated with its phytochemical content. The levels of total phenolics, flavonoids and condensed tannins were 23.37mgGAE/g, 9.05mgQE/g and 9.35mgTAE/g, respectively. HPLC analysis revealed nine compounds, namely rutin, resveratrol, coumarin, epicatechin, luteolin, catechin, kaempferol, vanillic acid and gallic acid. The MECS showed interesting antioxidant capacity. The MECS-treatment significantly reduced the increased plasma levels of creatinine, urea and uric acid, reduced the elevated MDA levels, significantly reduced the antioxidant enzyme activities and restored the kidney damage, provoked by cisplatin-treatment. Furthermore, MECS-treatment significantly prevented the increase in serum ALT, AST and LDH levels in acute liver damage induced by CCl4, decreased the amount of hepatic malondialdehyde (MDA) formation and elevated the activities of SOD, CAT and GPx, and restored liver injury. This study supports the traditionally use of C. spinosa to cure kidney and liver diseases. The obtained results highlighted the possible use of C. spinosa as a source of phytochemical with important biological advantages.

KEYWORDS:

Antioxidant; Capparis spinosa; Hepatoprotective; Nephroprotective; Phytochemical
PMID:
 
28056421
 
DOI:
 
10.1016/j.biopha.2016.12.052

The relationship between metabolic risk factors and incident cardiovascular disease in Europeans, South Asians, and African Caribbeans: SABRE (Southall and Brent Revisited) -- a prospective population-based study.

 2013 Apr 30;61(17):1777-86. doi: 10.1016/j.jacc.2012.12.046. Epub 2013 Feb 28.


Author information

1
International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London, London, United Kingdom. t.tillin@imperial.ac.uk

Abstract

OBJECTIVES:

This study sought to determine whether ethnic differences in diabetes, dyslipidemia, and ectopic fat deposition account for ethnic differences in incident cardiovascular disease.

BACKGROUND:

Coronary heart disease risks are elevated in South Asians and are lower in African Caribbeans compared with Europeans. These ethnic differences map to lipid patterns and ectopic fat deposition.

METHODS:

Cardiovascular risk factors were assessed in 2,049 Europeans, 1,517 South Asians, and 630 African Caribbeans from 1988 through 1991 (mean age: 52.4 ± 6.9 years). Fatal and nonfatal events were captured over a median 20.5-year follow-up. Subhazard ratios (SHR) were calculated using competing risks regression.

RESULTS:

Baseline diabetes prevalence was more than 3 times greater in South Asians and African Caribbeans than in Europeans. South Asians were more and African Caribbeans were less centrally obese and dyslipidemic than Europeans. Compared with Europeans, coronary heart disease incidence was greater in South Asians and less in African Caribbeans. The age- and sex-adjusted South Asian versus European SHR was 1.70 (95% confidence interval [CI]: 1.52 to 1.91, p < 0.001) and remained significant (1.45, 95% CI: 1.28 to 1.64, p < 0.001) when adjusted for waist-to-hip ratio. The African Caribbean versus European age- and sex-adjusted SHR of 0.64 (95% CI: 0.52 to 0.79, p < 0.001) remained significant when adjusted for high-density lipoprotein and low-density lipoprotein cholesterol (0.74, 95% CI: 0.60 to 0.92, p = 0.008). Compared with Europeans, South Asians and African Caribbeans experienced more strokes (age- and sex-adjusted SHR: 1.45 [95% CI: 1.17 to 1.80, p = 0.001] and 1.50 [95% CI: 1.13 to 2.00, p = 0.005], respectively), and this differential was more marked in those with diabetes (age-adjusted SHR: 1.97 [95% CI: 1.16 to 3.35, p = 0.038 for interaction] and 2.21 [95% CI: 1.14 to 4.30, p = 0.019 for interaction]).

CONCLUSIONS:

Ethnic differences in measured metabolic risk factors did not explain differences in coronary heart disease incidence. The apparently greater association between diabetes and stroke risk in South Asians and African Caribbeans compared with Europeans merits further study.

Comment in

PMID:
 
23500273
 
PMCID:
 
PMC3677086
 
DOI:
 
10.1016/j.jacc.2012.12.046
[Indexed for MEDLINE] 
Free PMC Article